Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
PRECISION BIOSCIENCES INC (DTIL)
Standardized SEC financial data for PRECISION BIOSCIENCES INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001357874 · NASDAQ · Biological Products, (No Diagnostic Substances).
Operating margin
-152.2%
Net margin
-133.4%
Revenue growth (YoY)
-50.1%
Return on equity
-49.6%
ROIC
-1000.0%
Free cash flow
-$65.9M
Debt / equity
0.24×
Current ratio
13.32×
Ratios for fiscal year 2025, standardized from SEC filings.